A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ.
Bond GL, et al. Among authors: hu w.
Cell. 2004 Nov 24;119(5):591-602. doi: 10.1016/j.cell.2004.11.022.
Cell. 2004.
PMID: 15550242
Free article.